Correction to: Experimental & Molecular Medicine (2018) 50:e435; https://doi.org/10.1038/emm.2017.248; Published Online 26 January 2018.
After online publication of this article, the authors noticed errors in the Fig. 4c and Fig. 5c section.
Fig. 4c
Fig. 5c
The correct statement of this article should have read as below.
The corrected data were printed below. These corrected results do not alter the conclusions of this article. The authors apologize for any inconvenience caused.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jeong, B.Y., Cho, K.H., Jeong, K.J. et al. Author Correction: Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin. Exp Mol Med 50, 1–2 (2018). https://doi.org/10.1038/s12276-018-0148-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s12276-018-0148-4
This article is cited by
-
The YB-1/EZH2/amphiregulin signaling axis mediates LPA-induced breast cancer cell invasion
Archives of Pharmacal Research (2019)
